Table 2.
Citrate hemofiltration was started to reduce the risk of systemic anticoagulation
Day | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | → |
---|---|---|---|---|---|---|---|---|---|
Plasmaseparation | Citrate | Citrate | Citrate | Citrate | Citrate | Citrate | Citrate | Citrate | → |
Hemofiltration | Citrate | Citrate | Heparin | Heparin | Argatroban | Argatroban | Argatroban | → | |
↑ | ↑ | ||||||||
Decrease of hemoptysis | Thrombocytopenia |
Notes: Decreasing hemoptysis enabled a change to heparin on day 4. Because of developing thrombocytopenia hemofiltration was continued on argatroban. Plasmapheresis was administered with citrate as standard in our department. ↑, increased; →, ongoing treatment.